These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 7660786)

  • 21. Comparative study of vasodilators in an animal model of chronic volume overload caused by severe aortic regurgitation.
    Plante E; Lachance D; Beaudoin J; Champetier S; Roussel E; Arsenault M; Couet J
    Circ Heart Fail; 2009 Jan; 2(1):25-32. PubMed ID: 19808312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
    Gao S; Long CL; Wang RH; Wang H
    Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of menidipine on dihydropyridines binding sites in cardiac and cerebral membranes from old rats with left ventricular hypertrophy.
    Xi T; Rao MR
    Zhongguo Yao Li Xue Bao; 1996 May; 17(3):235-8. PubMed ID: 9812745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A role of fatty acid oxidation in cardiac hypertrophy.
    Bressler R; Goldman S
    Cardioscience; 1993 Sep; 4(3):133-42. PubMed ID: 8400020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitogen-activated protein kinases (p38 and c-Jun NH2-terminal kinase) are differentially regulated during cardiac volume and pressure overload hypertrophy.
    Sopontammarak S; Aliharoob A; Ocampo C; Arcilla RA; Gupta MP; Gupta M
    Cell Biochem Biophys; 2005; 43(1):61-76. PubMed ID: 16043884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antihypertensive agents that limit ventricular hypertrophy inhibit cardiac expression of insulin-like growth factor-I.
    Donohue TJ; Dworkin LD; Ma J; Lango MN; Catanese VM
    J Investig Med; 1997 Dec; 45(9):584-91. PubMed ID: 9444886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of angiotensin II receptor blockade on pressure-induced left ventricular hypertrophy and fibrosis in rats.
    Baba HA; Iwai T; Bauer M; Irlbeck M; Schmid KW; Zimmer HG
    J Mol Cell Cardiol; 1999 Feb; 31(2):445-55. PubMed ID: 10093056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of quinapril, losartan and hydralazine on cardiac hypertrophy and beta-adrenergic neuroeffector mechanisms in transgenic (mREN2)27 rats.
    Zolk O; Flesch M; Schnabel P; Teisman AC; Pinto YM; van Gilst WH; Paul M; Böhm M
    Br J Pharmacol; 1998 Feb; 123(3):405-12. PubMed ID: 9504380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of angiotensin II receptor blockade on hypoxia-induced right ventricular hypertrophy in rats.
    Irlbeck M; Iwai T; Lerner T; Zimmer HG
    J Mol Cell Cardiol; 1997 Nov; 29(11):2931-9. PubMed ID: 9405168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ultrastructure of the myocardium in the calcium channel blocker withdrawal syndrome].
    Devecka V; Kovácsová B; Svec P
    Bratisl Lek Listy; 1992 Dec; 93(12):605-9. PubMed ID: 1296850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Problems caused by withdrawal of beta blockers].
    Gadeholt G
    Tidsskr Nor Laegeforen; 1990 May; 110(12):1543-4. PubMed ID: 1971125
    [No Abstract]   [Full Text] [Related]  

  • 32. Beta blocker withdrawal: the role of the beta adrenoceptor.
    Maling TJ
    N Z Med J; 1984 Feb; 97(749):76-7. PubMed ID: 6142439
    [No Abstract]   [Full Text] [Related]  

  • 33. Beta-blocker withdrawal syndrome.
    Lederballe Pedersen O; Mikkelsen E
    Lancet; 1979 Mar; 1(8115):554-5. PubMed ID: 85137
    [No Abstract]   [Full Text] [Related]  

  • 34. [Are there any withdrawal complications with nitro derivatives and calcium antagonists?].
    Guerot C
    Therapie; 1985; 40(1):35-9. PubMed ID: 4002182
    [No Abstract]   [Full Text] [Related]  

  • 35. Beta-blocker withdrawal syndrome.
    Ross PJ; Lewis MJ; Henderson AH
    Lancet; 1979 Apr; 1(8121):875. PubMed ID: 86119
    [No Abstract]   [Full Text] [Related]  

  • 36. Left ventricular hypertrophy is prevalent in sprague-dawley rats.
    Clifford CB; Pritchett-Corning K; Mulder GB
    Comp Med; 2011 Feb; 61(1):11-2; author reply 12. PubMed ID: 21819675
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effects of calcium antagonists on withdrawal of beta-receptor blockers in rats during left ventricular hypertrophy].
    Li QP; Rao MR
    Yao Xue Xue Bao; 1995; 30(1):21-6. PubMed ID: 7660786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of m-nifedipine and nifedipine on hemodynamics in renovascular hypertensive rats].
    Yang JR; Xi T; Wu DM; Rao MR
    Zhongguo Yao Li Xue Bao; 1994 May; 15(3):260-3. PubMed ID: 7976383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of m-Nif and Nif on left ventricle hypertrophy in rats induced by partial ligation of abdominal aorta].
    Rao MR; Liu M; Ji Y
    Yao Xue Xue Bao; 1996; 31(9):647-51. PubMed ID: 9863228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of m-nifedipine on dihydropyridine binding sites in cardiac and cerebral cortex cell membranes from left ventricular hypertrophied rats.
    Xi T; Rao MR
    Zhongguo Yao Li Xue Bao; 1993 Sep; 14(5):405-9. PubMed ID: 8010027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.